- STAFF PICKS
- GIFTS + GIFT CARDS
- SELL BOOKS
- FIND A STORE
Ships in 1 to 3 days
Other titles in the Basic and Clinical Oncology series:
Basic and Clinical Oncology #25: Controversies in Lung Cancerby Benjamin Movsas Et Al.
Synopses & Reviews
Presenting contrasting viewpoints of leading national and international authorities, this illuminating reference explores unresolved issues in the treatment of patients with lung cancer. Providing evidence-based approaches to specific concerns in therapeutic management, Controversies in Lung Cancer guides clinicians confronting decisions regarding day-to-day oncologic practice. Includes opposing opinions on, among other issues, the timing of thoracic radiotherapy for patients with limited stage small cell lung cancer, by Dr. Nevin Murray, British Columbia Cancer Agency, Vancouver, Canada, and Dr. Michael Perry, Ellis Fischel Cancer Center, Columbia, Missouri! Emphasizing quality of life, nutrition, and supportive care of lung cancer patients, Controversies in Lung Cancer considers 7dose intensification of chemotherapy in small cell and non-small cell lung cancer 7the value of three-dimensional conformal radiotherapy 7endobronchial brachytherapy 7management of superior sulcus tumors 7and more! With over 1700 literature references, drawings, photographs, and tables, Controversies in Lung Cancer is a timely resource for medical, radiation, and thoracic oncologists; thoracic surgeons; pulmonologists; hematologists; primary care physicians; nurses; and medical school students and residents in these disciplines.
Book News Annotation:
Identifying key areas where progress has been achieved and where continued work is likely to result in further improvement, this volume presents 28 contributions primarily by North American scientists and clinical researchers. Topics include the current inadequacies of the staging system and possibilities for improving it; results achieved in limited-stage small cell lung cancer; dilemmas regarding local therapy (including proper timing, volume, and fractionation schedule for radiation therapy) and surgical treatment; novel strategies to improve outcome in selected groups of locally advanced non-small cell lung cancer patients; the role of adjuvant postoperative chemotherapy and radiation therapy; surgery versus chemoradiation in patients with marginally resectable stage III disease; and opposing viewpoints on a recently emerging controversy over three-dimensional conformal radiation therapy versus conventional radiation in lung cancer. Includes current discussion of supportive care, chemoprevention, endobronchial therapy, economic and resource analyses, and the role of chemotherapy dose intensification in non-small cell lung cancer.
Annotation c. Book News, Inc., Portland, OR (booknews.com)
What Our Readers Are Saying